What is Generate Biomedicines, Inc. 's EBITDA?

Generate Biomedicines, Inc. (GENB) reported EBITDA of -$60.84M in Q1 2026.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Generate Biomedicines, Inc. GENB EBITDA

EBITDA at other companies

ConstelliumCSTM

$384M+127%

Power IntegrationsPOWI

$8.02M-43.4%

Liberty EnergyLBRT

$136.34M-6.6%

Ryan Specialty HoldingsRYAN

$98.66M-4.1%

MDU Resources GroupMDU

$169.88M+3.5%

Remitly Global, Inc.RELY

$59.94M+240%

Other financials

Income statement

See full

Revenue$7.2M-18.1%

Operating income-$64.1M-33.1%

Net income-$61.4M-47.4%

EPS (diluted)-$1.07+34.0%

Balance sheet

See full

Cash & equivalents$160.6M-27.2%

Total debt$65.6M—

Total equity$514.8M+209%

Total assets$625.7M—

Cash flow

See full

Operating cash flow-$80.4M-51.2%

CapEx$3.8M+403%

Free cash flow-$84.2M-56.1%

Valuation

See full

Market cap$1.86B—

Enterprise value$1.76B—

Returns & leverage

See full

Debt / equity0.1×—

Current ratio9.2×—

Where this comes from

Calculated from Generate Biomedicines, Inc. ’s reported figures.

−$64.1Mebit+

$3.3MDepreciation Depletion & Amortization

=-$60.84M

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's EBITDA?: Generate Biomedicines, Inc. (GENB) reported EBITDA of -$60.84M in Q1 2026.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.